1 min read
1 min read
HIV/AIDS Drug Promotion by J&J and Janssen Results in $150 Million Legal Damages
A
Anmol Tiwari
July 2, 2024

United States Of America Et Al V. Johnson & Johnson Et Al
- Court: New Jersey State, Trenton Division, District Court
- Case Number: 3:12cv7758
- Filed: December 18, 2012
- Judges: Zahid N. Quraishi| Brendan Day
- Case Type: False Claims Act (375)
- Cause: False Claims Act
Parties Involved
- Plaintiff(s): Jessica Penelow | Christine Brancaccio | United States of America
- Counsel for Plaintiff: Peter S. Pearlman| William H Ellerbe
- Experts for Plaintiff(s): Israel Shaked | Mr. Ian Dew | Virginia Evans
- Defendant(s): Johnson & Johnson | Janssen Products, L.P. | Johnson & Johnson
- Counsel for Defendants: Melissa Anne Chuderewicz | Ronni E. Fuchs | Allison Brown | Brian M. Nichilo | Jason John Moreira | Logan Nicholas Anderson
- Experts for Defendant(s): Jon Smollen | Dr. Anupam Jena | Dr. Eric
Continue Reading This Article
Subscribe to access this article and our entire library of legal content.
Unlimited access to all articles
Expert legal analysis and insights
Downloadable resources and templates
Categories
Tags
Flase Claims Act
HIV/AIDS
J&J / Janssen
off-label marketing
flase claims act
hiv/aids
j&j / janssen